FDA regulation of stem-cell-based therapies.
Halme
Dina Gould
DG
School of Medicine, University of California at San Francisco, San Francisco, USA.
Kessler
David A
DA
D001688:Biological Products / Q000627:therapeutic use; D033041:Embryo Research / Q000331:legislation & jurisprudence; D004622:Embryo, Mammalian / Q000166:cytology; D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007883:Legislation, Medical; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence*; D013234:Stem Cells; D014019:Tissue Donors / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D001688:Biological Products